To aid in the development of immuno-oncology drugs, Creative Biolabs provides co-culture models of tumor organs and neo-T cells.
Neo-T cells can be a key component of customized immunotherapy since they have the selectivity to target particular malignancies since each patient's tumor has a different tumor genome mutation. Precision therapy for specific malignancies can be accomplished by growing and activating a patient's own neo-T cells in vitro before re-injecting them into the patient.
By identifying and observing the presence and activity of neo-T cells, one may both comprehend the tumor-killing effect and provide the groundwork for the modification of personalized therapy regimens.
Understanding neo-T cell function can help in the development of therapeutic methods that target immunological escape as well as improve awareness of the mechanisms.
Neo-T cell counts and activity in tumor samples can be examined to predict how well patients would respond to immunotherapy.
Fig. 1 Neo-T cells immunotherapy.1,3
Observing the interaction of T cells with tumor cells in tumor organ-like structures will allow us to better understand how neo-T cells recognize and destroy tumor cells.
The effect of various therapeutic approaches on tumor organoid structures and neo-T cells can be studied by incorporating medications or checkpoint inhibitors into the model.
Individualized tumor organ-like structures can be constructed using tumor samples from patients, and then tested against different immunotherapy strategies to determine the best treatment option.
Fig 1. Schematic diagram of patient-derived 3D organoid–T cell co-culture models and application.2,3
At Creative Biolabs, our team has extensive expertise in modeling tumor-immune interactions. With our combined efforts, our modeling services help scientists accelerate the discovery of more effective and safer drugs. Please contact us to learn more.
References